Physician

Kruti Sheth Nair, M.D.

According to 2025 Medicare claims, Kruti Nair, M.D. (NPI: 1588989966) practices hematology/oncology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Montgomery, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 77380-3883.

Nair's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 206,390 HCPCS/CPT codes, and received $3,167,245 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,335 prescription claims across 193 beneficiaries totaling $2,086,834 in drug costs, led by Revlimid (Lenalidomide). 2022 DME data shows 56 claims. Open Payments data shows 8 records totaling $172,588. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $75,873 to $3,167,245. Similarly, Part D prescription costs have risen steadily, from $3,616 to $2,086,834. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	27	2,846	$75,873
2017	105	18,476	$171,035
2018	120	23,095	$185,249
2019	204	87,372	$738,166
2020	199	80,006	$892,298
2021	277	129,214	$1,660,254
2022	308	162,845	$1,613,436
2023	376	183,886	$1,929,872
2024	436	206,390	$3,167,245

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	13	$3,616
2016	15	43	$19,327
2017	31	133	$65,578
2018	44	201	$470,442
2019	71	420	$873,031
2020	78	639	$606,132
2021	112	875	$1,179,127
2022	124	918	$1,224,506
2023	145	848	$762,972
2024	193	1,335	$2,086,834

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	15	$7,753
2018	N/R	27	$4,728
2019	N/R	N/R	N/R
2020	N/R	11	$1,929
2021	N/R	N/R	N/R
2022	N/R	56	$31,960
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	205	448	$90
80053	Blood test, comprehensive group of blood chemicals	240	659	$10
83550	Iron binding capacity	188	286	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	269	751	$8
83540	Iron level	188	286	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	49	1,372	$762,099
Jakafi	Ruxolitinib Phosphate	11	330	$185,424
Eliquis	Apixaban	205	8,052	$152,454
Abiraterone Acetate	Abiraterone Acetate	33	990	$43,181
Imatinib Mesylate	Imatinib Mesylate	11	330	$29,244

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$78	Hologic Sales and Service, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$172,510	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kruti Sheth Nair, M.D.?

Tedicare shows public-source Medicare data for Kruti Sheth Nair, M.D. (NPI 1588989966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kruti Sheth Nair, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kruti Sheth Nair, M.D.?

Kruti Sheth Nair, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Kruti Sheth Nair, M.D. have Open Payments data?

Kruti Sheth Nair, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.